Global Research Syndicate
No Result
View All Result
  • Latest News
  • Consumer Research
  • Survey Research
  • Marketing Research
  • Industry Research
  • Data Collection
  • More
    • Data Analysis
    • Market Insights
  • Latest News
  • Consumer Research
  • Survey Research
  • Marketing Research
  • Industry Research
  • Data Collection
  • More
    • Data Analysis
    • Market Insights
No Result
View All Result
globalresearchsyndicate
No Result
View All Result
Home Data Collection

Stewardship / Resistance Scan for Nov 18, 2019

globalresearchsyndicate by globalresearchsyndicate
November 19, 2019
in Data Collection
0
Stewardship / Resistance Scan for Nov 18, 2019
0
SHARES
4
VIEWS
Share on FacebookShare on Twitter

Audit finds EU efforts to fight antibiotic resistance are lacking

A new report from the European Court of Auditors (ECA) argues that while some progress has been made, European Union (EU) leaders need to do more to address the health burden of antibiotic resistance.

In their assessment of the European Commission and European Centre for Disease Prevention and Control’s management of key antibiotic resistance activities and resources, the auditors found that support for the “one health” approach was having some positive impacts, including more prudent use of veterinary antibiotics in most member states. But they also noted that there are big differences between the member states, that veterinary antibiotics use overall is still too high, and that gaps in collecting data and monitoring resistance in food animals and food remain. Incomplete surveillance data on hospital infections and insufficient knowledge of antibiotic-resistant pathogens in the environment were also cited as issues.

In addition, the auditors pointed out that while 99% of the EU’s antibiotic-resistance budget is devoted to research, there has not yet been any breakthrough in the development of new antibiotic classes, and the specific market challenges for new antibiotics have not been addressed.

“Antimicrobial resistance is a serious threat to public health,” ECA member Nikolaos Milionis said in a press release. “While there has been some progress on veterinary issues, the European Commission, together with the Member States, need to further step up their efforts to tackle this growing threat.” 

The report calls on the European Commission to provide more support for member state national action plans, promote better monitoring and use of veterinary antibiotics, and strengthen strategies for boosting antibiotic-resistance research.
Nov 15 ECA report
Nov 15 ECA press release

 

New guidance on drug-resistant TB prioritizes oral antibiotics

The American Thoracic Society (ATS), US Centers for Disease Control and Prevention (CDC), European Respiratory Society, and Infectious Diseases Society of America have published a practice guideline on treating drug-resistant tuberculosis (TB) that includes new recommendations for the choice and number of drugs in a regimen and duration of therapy, as well as the role of injectable drugs in multidrug-resistant TB (MDR-TB).

Writing in the American Journal of Respiratory and Critical Care Medicine, experts from the four organizations note that they analyzed data from 50 studies involving 12,030 patients total across 25 countries to develop the guideline.

The guideline makes clear that treatment should be tailored based on drug-susceptibility testing, and that patients should not receive medicines to which the Mycobacterium tuberculosis strain is resistant. It also prioritizes the use of oral medications.

The guideline recommends treatment with a later-generation fluoroquinolone for all infected contacts of patients who have MDR-TB, rather than watchful observation, and it provides evidence-based guidance for treating pregnant women who have MDR-TB. The experts also spell out the role of surgery in treating MDR-TB and advice for treating isoniazid-resistant TB.

“Having the participation of committee members from multiple medical societies and the CDC, as well as patient advocate perspectives, was absolutely critical to discussing the balance between desirable and undesirable health effects of interventions, making certain they were favorable for MDR-TB patients, including for children and pregnant women,” said Payam Nahid, MD, MPH, chair of the guideline committee, in an ATS news release.
Nov 15 Am J Respir Crit Care Med guideline
Nov 18 ATS news release

Related Posts

How Machine Learning has impacted Consumer Behaviour and Analysis
Consumer Research

How Machine Learning has impacted Consumer Behaviour and Analysis

July 12, 2023
Market Research The Ultimate Weapon for Business Success
Consumer Research

Market Research: The Ultimate Weapon for Business Success

June 29, 2023
Unveiling the Hidden Power of Market Research A Game Changer
Consumer Research

Unveiling the Hidden Power of Market Research: A Game Changer

June 29, 2023
7 Secrets of Market Research Gurus That Will Blow Your Mind
Consumer Research

7 Secrets of Market Research Gurus That Will Blow Your Mind

June 29, 2023
The Shocking Truth About Market Research Revealed!
Consumer Research

The Shocking Truth About Market Research: Revealed!

June 29, 2023
market research, primary research, secondary research, market research trends, market research news,
Consumer Research

Quantitative vs. Qualitative Research. How to choose the Right Research Method for Your Business Needs

June 29, 2023
Next Post
Multiple Sclerosiss Market Entry Strategies, Countermeasures Of Economic Impact & Forecast By 2027 | Biogen Idec, Novartis, EMD Serono, Sanofi, Teva Pharmaceutical

Multiple Sclerosiss Market Entry Strategies, Countermeasures Of Economic Impact & Forecast By 2027 | Biogen Idec, Novartis, EMD Serono, Sanofi, Teva Pharmaceutical

Categories

  • Consumer Research
  • Data Analysis
  • Data Collection
  • Industry Research
  • Latest News
  • Market Insights
  • Marketing Research
  • Survey Research
  • Uncategorized

Recent Posts

  • How Machine Learning has impacted Consumer Behaviour and Analysis
  • Market Research: The Ultimate Weapon for Business Success
  • Unveiling the Hidden Power of Market Research: A Game Changer
  • Privacy Policy
  • Terms of Use
  • Antispam
  • DMCA

Copyright © 2023 Globalresearchsyndicate.com

No Result
View All Result
  • Latest News
  • Consumer Research
  • Survey Research
  • Marketing Research
  • Industry Research
  • Data Collection
  • More
    • Data Analysis
    • Market Insights

Copyright © 2023 Globalresearchsyndicate.com

Login to your account below

Forgotten Password?

Fill the forms bellow to register

All fields are required. Log In

Retrieve your password

Please enter your username or email address to reset your password.

Log In
This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Cookie settingsACCEPT
Privacy & Cookies Policy

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these cookies, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may have an effect on your browsing experience.
Necessary
Always Enabled
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Non-necessary
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.
SAVE & ACCEPT